©The Author(s) 2021.
World J Hepatol. Nov 27, 2021; 13(11): 1707-1726
Published online Nov 27, 2021. doi: 10.4254/wjh.v13.i11.1707
Published online Nov 27, 2021. doi: 10.4254/wjh.v13.i11.1707
Table 5 Management during evaluation in acute phase
| Following thumb rules while attending to a patient with suspected mitochondrial disorder |
| Monitor closely for hypoglycemia and acidosis |
| Avoid lactated ringer’s solution for fluid administration: Worsens acidosis |
| Bicarbonate infusions as 1st line of defense |
| Avoid propofol for sedation/anesthesia |
| Avoid fasting > 12 h; avoid high rate glucose only infusions |
| Avoid drugs that are toxic to mitochondria: Chloramphenicol, valproate, aminoglycosides, phenytoin, carbamazapine, phenobarbital, statins, linezolid |
| Avoid drugs precipitating hepatopathy/liver dysfunction |
- Citation: Gopan A, Sarma MS. Mitochondrial hepatopathy: Respiratory chain disorders- ‘breathing in and out of the liver’. World J Hepatol 2021; 13(11): 1707-1726
- URL: https://www.wjgnet.com/1948-5182/full/v13/i11/1707.htm
- DOI: https://dx.doi.org/10.4254/wjh.v13.i11.1707